Diabetes & Metabolism Journal

Response

Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study (Diabetes Metab J 2025;49:498-506): Jwa-Kyung Kim, Kyung-Do Han, Jun Goo Kang; Diabetes Metab J. 2025;49(5):1139-1140. Published online September 1, 2025; DOI: https://doi.org/10.4093/dmj.2025.0593

2,144 View
36 Download

PDF PubReader ePub

Original Article

Complications
Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study: Jwa-Kyung Kim, Han Na Jung, Bum Jun Kim, Boram Han, Ji Hye Huh, Eun Roh, Joo-Hee Kim, Kyung-Do Han, Jun Goo Kang; Diabetes Metab J. 2025;49(3):498-506. Published online March 6, 2025; DOI: https://doi.org/10.4093/dmj.2024.0443

6,827 View
161 Download
8 Web of Science
5 Crossref

Background
Patients with diabetes are known to be at high risk for end-stage kidney disease (ESKD), but the accurate annual risk data for new-onset ESKD is still limited. In South Korea, the prevalence and incidence of ESKD are increasing more rapidly compared to the global average. This study aimed to determine the incidence rate (IR) of ESKD by diabetes status from 2012 to 2022.
Methods
Using data from the Korean National Health Insurance Service, we calculated the IR and hazard ratio (HR) for newonset ESKD in the general population. Individuals were categorized based on diabetes status into nondiabetes, impaired fasting glucose (IFG), diabetes duration <5 and ≥5 years.
Results
Among the participants, 67.6% were nondiabetic, 22.3% had IFG, and 10% had diabetes. In Korea, the IRs of ESKD were 139 per million population (pmp) for nondiabetes, 188 pmp for IFG, 632 pmp for diabetes <5 years, and 3,403 pmp for diabetes ≥5 years. An advanced estimated glomerular filtration rate (eGFR) category was the strongest risk factor for ESKD development. However, even in patients with normal renal function, those with long-standing diabetes had a 14-fold higher risk of ESKD compared to nondiabetic individuals. The risk of ESKD associated with diabetes increased exponentially with declining renal function. Notably, IFG showed an increasing tendency for ESKD in younger patients (<65 years) with early-stage chronic kidney disease (CKD; eGFR ≥60 mL/min/1.73 m²).
Conclusion
Longer diabetes duration amplifies ESKD risk, particularly as renal function declines. Even in patients with normal renal function, long-standing diabetes significantly increases ESKD risk, while IFG is associated with elevated risk only in younger individuals with early-stage CKD.

Citations

Citations to this article as recorded by

Development and validation of a machine learning model to predict comorbid hypertension in patients with type 2 diabetes
Hailu Yang, Changfeng Fan, Chunyan Liu
Frontiers in Medicine.2026;[Epub] CrossRef
Effectiveness and Safety of Finerenone in Patients With Diabetic Kidney Disease: A Real‐World Observational Study
Jaehyun Bae, Minyoung Lee, Hyung Woo Kim, Jung Tak Park, Seung Hyeok Han, Byung‐Wan Lee, Eun Seok Kang, Bong‐Soo Cha, Tae‐Hyun Yoo, Yong‐ho Lee
Diabetes, Obesity and Metabolism.2026; 28(7): 6245. CrossRef
Alcohol use disorder as an independent risk factor for end‐stage kidney disease: A nationwide population‐based cohort study in Korea
Jwa‐Kyung Kim, Myung Jin Kim, Sejin Kim, Han Na Jung, Bum Jun Kim, Boram Han, Ji‐Won Park, Sung‐Eun Kim, Ji Hye Heo, Joo‐Hee Kim, Kyung‐Do Han, Jun Goo Kang
Addiction.2026;[Epub] CrossRef
Targeting HDAC6 mitigates diabetic nephropathy through modulation of oxidative stress, inflammatory pathways, and apoptotic signaling
Ui Jin Kim, Eunah Lee, Ju Ri Kim, Yun Jeong Song, Yeong Eun Cho, Oh Kwang Kwon, Jae Hyeon Park, Hyung Sik Kim
Biochemical Pharmacology.2026; 253: 118283. CrossRef
Serum ketone body levels and risk of incident kidney and cardiovascular events among patients with type 2 diabetes: a prospective cohort study
Soo Myoung Shin, Jiyoon Lee, Young-Eun Kim, Jung A. Kim, Kyoung Jin Kim, Kyeong Jin Kim, Hee Young Kim, Sin Gon Kim, Nam Hoon Kim
Diabetes Research and Clinical Practice.2026; 239: 113476. CrossRef

First
Prev
Page of 1
Next
Last

Search